BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Feb 28, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-02-26

Reporting Person: LAPALME PIERRE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-26	Common Stock	M	9900	$8.47	Acquired	34550	Direct
2013-02-26	Common Stock	M	20000	$11.15	Acquired	54550	Direct
2013-02-26	Common Stock	S	29900	$55.3444	Disposed	24650	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-26	Stock Option (right to buy)	$8.47	M	9900	Disposed	2014-01-26	Common Stock (9900)	Direct
2013-02-26	Stock Option (right to buy)	$11.15	M	20000	Disposed	2016-01-26	Common Stock (20000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1500	Indirect

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $54.98 to $55.76. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: Options vest 1/4th each on April 27, 2004, July 27, 2004, October 27, 2004, and January 27, 2005.

F3: Options vest 1/4th each on April 27, 2006, July 27, 2006, October 27, 2006, and January 27, 2007.